Author:
Medigeshi Guruprasad R,Islam Farzana,Lodha Rakesh
Funder
India Ministry of Science & Technology Department of Biotechnology
Reference10 articles.
1. Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey;Murhekar;Lancet Glob Health,2019
2. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial;Capeding;Lancet,2014
3. Live, attenuated, tetravalent butantan-dengue vaccine in children and adults;Kallás;N Engl J Med,2024
4. Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial;Tricou;Lancet Glob Health,2024
5. The global distribution and burden of dengue;Bhatt;Nature,2013
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献